Evolus’s Return On Capital Employed Overview
According to data from Benzinga Pro, during Q1, Evolus's (NASDAQ:EOLS) reported sales totaled $33.91 million. Despite a 3.72% increase in earnings, the company posted a loss of $17.50 million.
Barclays Upgrades Evolus to Equal-Weight, Raises Price Target to $10
Barclays analyst Balaji Prasad upgrades Evolus (NASDAQ:EOLS) from Underweight to Equal-Weight and raises the price target from $8 to $10.
Earnings Scheduled For May 10, 2022
Companies Reporting Before The Bell
• The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.
Earnings Scheduled For March 3, 2022
Companies Reporting Before The Bell
• Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million.
Evolus Expects Q4 FY21 Sales Better Than Anticipated, Issues FY22 Guidance
Evolus Inc (NASDAQ: EOLS) has posted
HC Wainwright & Co. Maintains Buy on Evolus, Lowers Price Target to $15
HC Wainwright & Co. analyst Douglas Tsao maintains Evolus (NASDAQ:EOLS) with a Buy and lowers the price target from $22 to $15.